<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>20(1)</volume><submitter>Wei B</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>This study aimed to evaluate whether the Homocysteine (Hcy) level was elevated in chronic obstructive pulmonary disease (COPD) patients and its correlation with the occurrence and acute progression of COPD.&lt;h4>Methods&lt;/h4>From November 2014 to November 2015, COPD patients were enrolled from Beijing Chao-yang Hospital, and the the biological and clinical data were collected. These patients were tested in the non-acute exacerbation period and the acute exacerbation period, so they were defined as AECOPD group and Non-AECOPD group. Besides, 50 healthy subjects were recruited and defined as control group. Total plasma Hcy levels (antibodies-online, USA) were determined by enzyme-linked immunosorbent assay. Correlation analysis was used to analyze the correlation between seru</pubmed_abstract><journal>BMC pulmonary medicine</journal><pagination>237</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7487947</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease.</pubmed_title><pmcid>PMC7487947</pmcid><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Wei B</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Tian T</pubmed_authors></additional><is_claimable>false</is_claimable><name>The diagnostic value of homocysteine for the occurrence and acute progression of chronic obstructive pulmonary disease.</name><description>&lt;h4>Background&lt;/h4>This study aimed to evaluate whether the Homocysteine (Hcy) level was elevated in chronic obstructive pulmonary disease (COPD) patients and its correlation with the occurrence and acute progression of COPD.&lt;h4>Methods&lt;/h4>From November 2014 to November 2015, COPD patients were enrolled from Beijing Chao-yang Hospital, and the the biological and clinical data were collected. These patients were tested in the non-acute exacerbation period and the acute exacerbation period, so they were defined as AECOPD group and Non-AECOPD group. Besides, 50 healthy subjects were recruited and defined as control group. Total plasma Hcy levels (antibodies-online, USA) were determined by enzyme-linked immunosorbent assay. Correlation analysis was used to analyze the correlation between seru</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Sep</publication><modification>2025-04-05T00:29:25.517Z</modification><creation>2020-09-19T07:01:11Z</creation></dates><accession>S-EPMC7487947</accession><cross_references><pubmed>32894108</pubmed><doi>10.1186/s12890-020-01265-w</doi></cross_references></HashMap>